FEB 1.7 Z004, 8. 510(k) SUMMARY '. This summary of safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR…
FEB *i, 7 20V.r 8. 5 10(k) SUMMARY This summary of safety and effectiveness information is being submitted in accordance with the requirements of SM4DA 1990 and 21 CFR 807.92.…
J 8. SUMMARY OF510(k) This summary of safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92. The Assigned…
DEVELOPMENT OF DIAGNOSTIC PAN-ENTEROVIRUS MONOCLONAL ANTIBODIES USING VP1 RECOMBINANT PROTEINS Lynn Yihong Miao, Christina Pierce, Sarah Peaslee, Carl Shaw, April Brandon,…
510(k) Submissions Recent Experience and Perspectives Terry Sullivan Vice President, Regulatory Affairs * What I will cover today... Survey of audience Overview of 510(k)…